Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 211

1.

Hepatorenal Syndrome.

Francoz C, Durand F, Kahn JA, Genyk YS, Nadim MK.

Clin J Am Soc Nephrol. 2019 May 7;14(5):774-781. doi: 10.2215/CJN.12451018. Epub 2019 Apr 17.

PMID:
30996046
2.

Risk perceptions after human papillomavirus vaccination are not subsequently associated with riskier behaviors or sexually transmitted infections in HIV-infected young women.

Thomas R, Dillard M, Xu J, Zimet GD, Kahn JA.

Hum Vaccin Immunother. 2019 Feb 20. doi: 10.1080/21645515.2019.1582401. [Epub ahead of print]

PMID:
30785355
3.

Human Papillomavirus Vaccine Effectiveness and Herd Protection in Young Women.

Spinner C, Ding L, Bernstein DI, Brown DR, Franco EL, Covert C, Kahn JA.

Pediatrics. 2019 Feb;143(2). pii: e20181902. doi: 10.1542/peds.2018-1902. Epub 2019 Jan 22.

PMID:
30670582
4.

Pre-vaccination prevalence of anogenital and oral human papillomavirus in young HIV-infected men who have sex with men.

Kahn JA, Belzer M, Chi X, Lee J, Gaur AH, Mayer K, Martinez J, Futterman DC, Stier EA, Paul ME, Chiao EY, Reirden D, Goldstone SE, Ortiz Martinez AP, Cachay ER, Barroso LF, Da Costa M, Wilson CM, Palefsky JM; AIDS Malignancy Consortium and Adolescent Medicine Trials Network for HIV/AIDS Interventions.

Papillomavirus Res. 2019 Jan 15;7:52-61. doi: 10.1016/j.pvr.2019.01.002. [Epub ahead of print]

5.

Maternal Factors and Sexual Orientation-Related Disparities in Cervical Cancer Prevention.

Charlton BM, Kahn JA, Sarda V, Katz-Wise SL, Spiegelman D, Missmer SA, Austin SB.

Womens Health Issues. 2019 Jan 10. pii: S1049-3867(18)30414-6. doi: 10.1016/j.whi.2018.12.001. [Epub ahead of print]

PMID:
30639277
6.

Evidence for cross-protection but not type-replacement over the 11 years after human papillomavirus vaccine introduction.

Covert C, Ding L, Brown D, Franco EL, Bernstein DI, Kahn JA.

Hum Vaccin Immunother. 2019 Jan 11:1-8. doi: 10.1080/21645515.2018.1564438. [Epub ahead of print]

PMID:
30633598
7.

Primary Care Physician Attitudes and Intentions Toward the Use of HIV Pre-exposure Prophylaxis in Adolescents in One Metropolitan Region.

Mullins TLK, Idoine CR, Zimet GD, Kahn JA.

J Adolesc Health. 2019 May;64(5):581-588. doi: 10.1016/j.jadohealth.2018.10.300. Epub 2018 Dec 19.

PMID:
30578115
8.

Incidental Coronary Artery Calcification Seen on Low-Dose Computed Tomography Is a Risk Factor for Obstructive Coronary Artery Disease in Patients Undergoing Liver Transplant.

Othman T, Tun H, Bainiwal JS, Andersen ES, Dharmavaram NL, Schwartzman WS, Baffo AN, Butera BC, Phuong NS, Xu PZ, Yasmeh B, Gertsvolf NA, Yoon AJ, Shavelle DM, Garg PK, Van Herle HM, Kahn JA, Kim B.

Transplant Proc. 2018 Dec;50(10):3487-3495. doi: 10.1016/j.transproceed.2018.11.001. Epub 2018 Nov 9.

9.

Florida physicians' reported use of AFIX-based strategies for human papillomavirus vaccination.

Kasting ML, Christy SM, Sutton SK, Lake P, Malo TL, Roetzheim RG, Schechtman T, Zimet GD, Walkosz BJ, Salmon D, Kahn JA, Giuliano AR, Vadaparampil ST.

Prev Med. 2018 Nov;116:143-149. doi: 10.1016/j.ypmed.2018.09.004. Epub 2018 Sep 13.

PMID:
30219689
10.

Epidemiology of Any and Vaccine-Type Anogenital Human Papillomavirus Among 13-26-Year-Old Young Men After HPV Vaccine Introduction.

Chandler E, Ding L, Gorbach P, Franco EL, Brown DA, Widdice LE, Bernstein DI, Kahn JA.

J Adolesc Health. 2018 Jul;63(1):43-49. doi: 10.1016/j.jadohealth.2018.01.005.

PMID:
30060856
11.

Faculty Members' Self-Awareness, Leadership Confidence, and Leadership Skills Improve after an Evidence-Based Leadership Training Program.

Hackworth J, Steel S, Cooksey E, DePalma M, Kahn JA.

J Pediatr. 2018 Aug;199:4-6.e2. doi: 10.1016/j.jpeds.2018.05.007. No abstract available.

PMID:
30049400
12.

US Health Care Clinicians' Knowledge, Attitudes, and Practices Regarding Human Papillomavirus Vaccination: A Qualitative Systematic Review.

Rosen BL, Shepard A, Kahn JA.

Acad Pediatr. 2018 Mar;18(2S):S53-S65. doi: 10.1016/j.acap.2017.10.007. Review.

PMID:
29502639
13.

Non-Vaccine-Type Human Papillomavirus Prevalence After Vaccine Introduction: No Evidence for Type Replacement but Evidence for Cross-Protection.

Saccucci M, Franco EL, Ding L, Bernstein DI, Brown D, Kahn JA.

Sex Transm Dis. 2018 Apr;45(4):260-265. doi: 10.1097/OLQ.0000000000000731.

PMID:
29465705
14.

Prevalence of potential sexual abuse in adolescents and young adults and feasibility of an assessment and management plan used in three research projects.

Morrow C, Thomas R, Ding L, Kahn JA.

Res Nurs Health. 2018 Apr;41(2):166-172. doi: 10.1002/nur.21850. Epub 2018 Feb 21.

PMID:
29464734
15.

Quality of Web-Based Educational Interventions for Clinicians on Human Papillomavirus Vaccine: Content and Usability Assessment.

Rosen BL, Bishop JM, McDonald SL, Kahn JA, Kreps GL.

JMIR Cancer. 2018 Feb 16;4(1):e3. doi: 10.2196/cancer.9114.

16.

Caregiver and adolescent factors associated with delayed completion of the three-dose human papillomavirus vaccination series.

Widdice LE, Hoagland R, Callahan ST, Kahn JA, Harrison CJ, Pahud BA, Frey SE, Berry AA, Kotloff KL, Edwards KM, Mulligan MJ, Sudman J, Nakamura A, Bernstein DI.

Vaccine. 2018 Mar 7;36(11):1491-1499. doi: 10.1016/j.vaccine.2017.12.060. Epub 2018 Feb 7.

17.

HIV Care Providers' Intentions to Prescribe and Actual Prescription of Pre-Exposure Prophylaxis to At-Risk Adolescents and Adults.

Mullins TLK, Zimet G, Lally M, Xu J, Thornton S, Kahn JA.

AIDS Patient Care STDS. 2017 Dec;31(12):504-516. doi: 10.1089/apc.2017.0147.

18.

Human Papillomavirus Vaccine Sources of Information and Adolescents' Knowledge and Perceptions.

Rosen BL, Shew ML, Zimet GD, Ding L, Mullins TLK, Kahn JA.

Glob Pediatr Health. 2017 Nov 24;4:2333794X17743405. doi: 10.1177/2333794X17743405. eCollection 2017.

19.

Human Papillomavirus Vaccine-Related Risk Perceptions Do Not Predict Sexual Initiation Among Young Women Over 30 Months Following Vaccination.

Mullins TLK, Rosenthal SL, Zimet GD, Ding L, Morrow C, Huang B, Kahn JA.

J Adolesc Health. 2018 Feb;62(2):164-169. doi: 10.1016/j.jadohealth.2017.09.008. Epub 2017 Dec 2.

20.

Differences between vaccinated and unvaccinated women explain increase in non-vaccine-type human papillomavirus in unvaccinated women after vaccine introduction.

Ding L, Widdice LE, Kahn JA.

Vaccine. 2017 Dec 19;35(52):7217-7221. doi: 10.1016/j.vaccine.2017.11.005. Epub 2017 Nov 21.

21.

Who's Not Protected in the Herd? Factors Associated with Vaccine-Type HPV in Unvaccinated Women.

Smith C, Ding L, Gorbach PM, Franco EL, Kahn JA.

J Pediatr Adolesc Gynecol. 2018 Apr;31(2):89-93. doi: 10.1016/j.jpag.2017.09.008. Epub 2017 Sep 21.

22.

A Qualitative Analysis of Adolescent and Caregiver Acceptability of Universally Offered Gonorrhea and Chlamydia Screening in the Pediatric Emergency Department.

Reed JL, Punches BE, Taylor RG, Macaluso M, Alessandrini EA, Kahn JA.

Ann Emerg Med. 2017 Dec;70(6):787-796.e2. doi: 10.1016/j.annemergmed.2017.04.017. Epub 2017 May 27.

PMID:
28559031
23.

Brief Report: Antibody Responses to Quadrivalent HPV Vaccination in HIV-Infected Young Women as Measured by Total IgG and Competitive Luminex Immunoassay.

Kahn JA, Xu J, Kapogiannis BG, Sleasman JW.

J Acquir Immune Defic Syndr. 2017 Jun 1;75(2):241-245. doi: 10.1097/QAI.0000000000001355.

24.

HIV-Infected Young Men Demonstrate Appropriate Risk Perceptions and Beliefs about Safer Sexual Behaviors after Human Papillomavirus Vaccination.

Kahn JA, Lee J, Belzer M, Palefsky JM; AIDS Malignancy Consortium and Adolescent Medicine Trials Network for HIV/AIDS Interventions.

AIDS Behav. 2018 Jun;22(6):1826-1834. doi: 10.1007/s10461-017-1710-0.

PMID:
28220313
25.

Detection of Occult Hepatitis C Virus Infection in Patients Who Achieved a Sustained Virologic Response to Direct-Acting Antiviral Agents for Recurrent Infection After Liver Transplantation.

Elmasry S, Wadhwa S, Bang BR, Cook L, Chopra S, Kanel G, Kim B, Harper T, Feng Z, Jerome KR, Kahn JA, Saito T.

Gastroenterology. 2017 Feb;152(3):550-553.e8. doi: 10.1053/j.gastro.2016.11.002. Epub 2016 Nov 9.

26.

Substantial Decline in Vaccine-Type Human Papillomavirus (HPV) Among Vaccinated Young Women During the First 8 Years After HPV Vaccine Introduction in a Community.

Kahn JA, Widdice LE, Ding L, Huang B, Brown DR, Franco EL, Bernstein DI.

Clin Infect Dis. 2016 Nov 15;63(10):1281-1287. Epub 2016 Sep 20.

27.

Distribution of Vaccine-Type Human Papillomavirus Does Not Differ by Race or Ethnicity Among Unvaccinated Young Women.

Whittemore D, Ding L, Widdice LE, Brown DA, Bernstein DI, Franco EL, Kahn JA.

J Womens Health (Larchmt). 2016 Nov;25(11):1153-1158. Epub 2016 Oct 18.

28.

Population-Level Effects of Human Papillomavirus Vaccination Programs on Infections with Nonvaccine Genotypes.

Mesher D, Soldan K, Lehtinen M, Beddows S, Brisson M, Brotherton JM, Chow EP, Cummings T, Drolet M, Fairley CK, Garland SM, Kahn JA, Kavanagh K, Markowitz L, Pollock KG, Söderlund-Strand A, Sonnenberg P, Tabrizi SN, Tanton C, Unger E, Thomas SL.

Emerg Infect Dis. 2016 Oct;22(10):1732-40. doi: 10.3201/eid2210.160675. Review.

29.

Missing the Target for Routine Human Papillomavirus Vaccination: Consistent and Strong Physician Recommendations Are Lacking for 11- to 12-Year-Old Males.

Vadaparampil ST, Malo TL, Sutton SK, Ali KN, Kahn JA, Casler A, Salmon D, Walkosz B, Roetzheim RG, Zimet GD, Giuliano AR.

Cancer Epidemiol Biomarkers Prev. 2016 Oct;25(10):1435-1446. Epub 2016 Aug 2.

30.

Adolescent Human Immunodeficiency Virus Care Providers' Attitudes Toward the Use of Oral Pre-Exposure Prophylaxis in Youth.

Mullins TL, Zimet G, Lally M, Kahn JA.

AIDS Patient Care STDS. 2016 Jul;30(7):339-48. doi: 10.1089/apc.2016.0048.

31.

Human papillomavirus vaccine-related risk perceptions and subsequent sexual behaviors and sexually transmitted infections among vaccinated adolescent women.

Mullins TL, Zimet GD, Rosenthal SL, Morrow C, Ding L, Huang B, Kahn JA.

Vaccine. 2016 Jul 25;34(34):4040-5. doi: 10.1016/j.vaccine.2016.06.026. Epub 2016 Jun 10.

32.

Rapid Antigen Testing for Trichomoniasis in an Emergency Department.

Postenrieder NR, Reed JL, Hesse E, Kahn JA, Ding L, Gaydos CA, Rompalo A, Widdice LE.

Pediatrics. 2016 Jun;137(6). pii: e20152072. doi: 10.1542/peds.2015-2072.

33.

Factors Associated With HPV Vaccine Initiation, Vaccine Completion, and Accuracy of Self-Reported Vaccination Status Among 13- to 26-Year-Old Men.

Thomas R, Higgins L, Ding L, Widdice LE, Chandler E, Kahn JA.

Am J Mens Health. 2018 Jul;12(4):819-827. doi: 10.1177/1557988316645155. Epub 2016 Apr 22.

34.

Prevalence and risk factors for oral DNA tumor viruses in HIV-infected youth.

Kahn JA, Rudy BJ, Xu J, Kapogiannis B, Secord E, Gillison M.

J Med Virol. 2016 Nov;88(11):1944-52. doi: 10.1002/jmv.24555. Epub 2016 May 9.

35.

Adolescents' intention and self-efficacy to follow Pap testing recommendations after receiving the HPV vaccine.

Higgins LM, Dirksing KN, Ding L, Morrow CD, Widdice LA, Kahn JA.

Hum Vaccin Immunother. 2016 Jun 2;12(6):1498-503. doi: 10.1080/21645515.2016.1150395. Epub 2016 Mar 2.

36.

Tempest in a teapot: A systematic review of HPV vaccination and risk compensation research.

Kasting ML, Shapiro GK, Rosberger Z, Kahn JA, Zimet GD.

Hum Vaccin Immunother. 2016 Jun 2;12(6):1435-50. doi: 10.1080/21645515.2016.1141158. Epub 2016 Feb 10. Review.

37.

Pressure ulcer risk of patient handling sling use.

Peterson MJ, Kahn JA, Kerrigan MV, Gutmann JM, Harrow JJ.

J Rehabil Res Dev. 2015;52(3):291-300. doi: 10.1682/JRRD.2014.06.0140.

38.

Risk perceptions, sexual attitudes, and sexual behavior after HPV vaccination in 11-12 year-old girls.

Mullins TL, Widdice LE, Rosenthal SL, Zimet GD, Kahn JA.

Vaccine. 2015 Jul 31;33(32):3907-12. doi: 10.1016/j.vaccine.2015.06.060. Epub 2015 Jun 23.

39.

Provider-Level Characteristics Associated With Adolescent Varicella, Meningococcal, and Human Papillomavirus Immunization Initiation.

Grout RL, Beal SJ, Kahn JA, Widdice LE.

Clin Pediatr (Phila). 2016 Jan;55(1):44-7. doi: 10.1177/0009922815584215. Epub 2015 May 11.

PMID:
25963176
40.

Behavioral, immunologic, and virologic correlates of oral human papillomavirus infection in HIV-infected youth.

Kahn JA, Rudy BJ, Xu J, Secord EA, Kapogiannis BG, Thornton S, Gillison ML.

Sex Transm Dis. 2015 May;42(5):246-52. doi: 10.1097/OLQ.0000000000000264.

41.

Innovative clinical and public health strategies to promote adolescent vaccination.

Kahn JA, Rickert VI.

J Adolesc Health. 2015 May;56(5 Suppl):S1-2. doi: 10.1016/j.jadohealth.2015.02.002. No abstract available.

42.

Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis.

Drolet M, Bénard É, Boily MC, Ali H, Baandrup L, Bauer H, Beddows S, Brisson J, Brotherton JM, Cummings T, Donovan B, Fairley CK, Flagg EW, Johnson AM, Kahn JA, Kavanagh K, Kjaer SK, Kliewer EV, Lemieux-Mellouki P, Markowitz L, Mboup A, Mesher D, Niccolai L, Oliphant J, Pollock KG, Soldan K, Sonnenberg P, Tabrizi SN, Tanton C, Brisson M.

Lancet Infect Dis. 2015 May;15(5):565-80. doi: 10.1016/S1473-3099(14)71073-4. Epub 2015 Mar 3. Review.

43.

Clinician attitudes toward CDC interim pre-exposure prophylaxis (PrEP) guidance and operationalizing PrEP for adolescents.

Mullins TL, Lally M, Zimet G, Kahn JA; Adolescent Medicine Trials Network for HIV/AIDS Interventions.

AIDS Patient Care STDS. 2015 Apr;29(4):193-203. doi: 10.1089/apc.2014.0273. Epub 2015 Feb 18.

44.

Adolescent patient preferences surrounding partner notification and treatment for sexually transmitted infections.

Reed JL, Huppert JS, Gillespie GL, Taylor RG, Holland CK, Alessandrini EA, Kahn JA.

Acad Emerg Med. 2015 Jan;22(1):61-6. doi: 10.1111/acem.12557. Epub 2014 Dec 24.

45.

Does intention to recommend HPV vaccines impact HPV vaccination rates?

Feemster KA, Middleton M, Fiks AG, Winters S, Kinsman SB, Kahn JA.

Hum Vaccin Immunother. 2014;10(9):2519-26. doi: 10.4161/21645515.2014.969613. Epub 2014 Oct 30.

46.

Education and Imaging: hepatology: portal vein cavernoma imitating cholangiocarcinoma in a patient with erythropoietic protoporphyria.

Saberi B, Deurdulian C, Pandya H, Kahn JA.

J Gastroenterol Hepatol. 2014 Oct;29(10):1755. doi: 10.1111/jgh.12729. No abstract available.

PMID:
25318384
47.

Physicians' human papillomavirus vaccine recommendations in the context of permissive guidelines for male patients: a national study.

Malo TL, Giuliano AR, Kahn JA, Zimet GD, Lee JH, Zhao X, Vadaparampil ST.

Cancer Epidemiol Biomarkers Prev. 2014 Oct;23(10):2126-35. doi: 10.1158/1055-9965.EPI-14-0344. Epub 2014 Jul 15.

48.

Improving sexually transmitted infection results notification via mobile phone technology.

Reed JL, Huppert JS, Taylor RG, Gillespie GL, Byczkowski TL, Kahn JA, Alessandrini EA.

J Adolesc Health. 2014 Nov;55(5):690-7. doi: 10.1016/j.jadohealth.2014.05.004. Epub 2014 Jun 21.

49.

The authoring committee responds.

English A, Ford CA, Kahn JA, Kharbanda EO, Middleman AB.

J Adolesc Health. 2014 May;54(5):620. doi: 10.1016/j.jadohealth.2014.02.012. No abstract available.

PMID:
24759360
50.

Imaging appearance in acute liver failure: correlation with clinical and pathology findings.

Romero M, Palmer SL, Kahn JA, Ihde L, Lin LM, Kosco A, Shinar R, Ghandforoush A, Chan LS, Petrovic LM, Sher LS, Fong TL.

Dig Dis Sci. 2014 Aug;59(8):1987-95. doi: 10.1007/s10620-014-3106-6. Epub 2014 Apr 2. Review.

PMID:
24691628

Supplemental Content

Support Center